CCM — CONCORD MED SVCS HLDGS LTD
As of Q2 2026, 3 SEC-registered investment managers reported holding CCM (CONCORD MED SVCS HLDGS LTD) in their latest 13F filings, with a combined reported value of $52.59K across 11.14K shares. That is +1458.5% by share count (+10.43K shares) versus the previous quarter, while reported value moved +1915.1%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CCM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 10.54K | $49.76K | 0.00% | New |
| UBS Group AG history | 500 | $2.36K | 0.00% | Reduce |
| Morgan Stanley history | 100 | $472 | 0.00% | Hold |
Q1 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 615 | $2.25K | 0.00% | Reduce |
| Morgan Stanley history | 100 | $365 | 0.00% | Hold |
Q4 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 863 | $3.33K | 0.00% | Reduce |
| Morgan Stanley history | 100 | $386 | 0.00% | Hold |
Q3 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 37.85K | $232.39K | 0.00% | Reduce |
| Morgan Stanley history | 100 | $614 | 0.00% | Hold |
Q2 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 67.92K | $389.18K | 0.00% | Add |
| Morgan Stanley history | 100 | $573 | 0.00% | New |
Q1 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 217 | $868 | 0.00% | Reduce |
New Positions (Q2 2026)
- Citadel Advisors 10.54K sh · $49.76K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 6 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 10.54K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 500 | 615 | 863 | 37.85K | 67.92K | 217 | 659 | 923 | 8.16K | — | 101 | 103 | — | 100 | 2.20K | 2.19K | 2.19K | 2.73K | 821 | 264 |
| Morgan Stanley | 100 | 100 | 100 | 100 | 100 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | 39.10K | 40.70K | 47.90K | 60.10K | 72.80K | 86.40K | 103.10K | 112.60K | 129.50K | 142.60K | 155.10K | 180.20K |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | 25 | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 200 | 221 | 221 | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details